Volume | 709,293 |
|
|||||
News | - | ||||||
Day High | 0.779999 | Low High |
|||||
Day Low | 0.752 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Assertio Holdings Inc | ASRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.77 | 0.752 | 0.779999 | 0.754 | 0.78 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,302 | 709,293 | $ 0.764154 | $ 542,009 | - | 0.752 - 8.01 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:37:14 | 20 | $ 0.7601 | USD |
Assertio Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
72.2M | 95.00M | - | 152.07M | -331.94M | -3.49 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Assertio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ASRT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.91 | 0.91 | 0.752 | 0.8238423 | 709,739 | -0.1371 | -15.07% |
1 Month | 1.05 | 1.09 | 0.752 | 0.9349799 | 770,087 | -0.2771 | -26.39% |
3 Months | 0.87 | 1.21 | 0.752 | 0.9447726 | 918,507 | -0.0971 | -11.16% |
6 Months | 2.50 | 2.50 | 0.752 | 1.15 | 1,234,997 | -1.73 | -69.08% |
1 Year | 6.16 | 8.01 | 0.752 | 3.40 | 1,672,611 | -5.39 | -87.45% |
3 Years | 0.4772 | 8.01 | 0.419 | 2.93 | 1,460,439 | 0.2957 | 61.97% |
5 Years | 4.26 | 8.01 | 0.33 | 1.70 | 2,330,008 | -3.49 | -81.86% |
Assertio Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. |